1-6 of 6
Phillip Gorden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study

Joanna Klubo-Gwiezdzinska, Maria Lange, Elaine Cochran, Robert K. Semple, Cornelia Gewert, Rebecca J. Brown, Phillip Gorden
Journal: Diabetes Care
Diabetes Care 2018;41(11):2353–2360
https://doi.org/10.2337/dc18-0884
Published: 10 September 2018
View article titled, Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study
Open the PDF for Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study in another window
Journal Articles

Management of Diabetic Ketoacidosis in Severe Insulin Resistance

Cemre Robinson, Elaine Cochran, Phillip Gorden, Rebecca J. Brown
Journal: Diabetes Care
Diabetes Care 2016;39(8):e116–e118
https://doi.org/10.2337/dc16-0635
Published: 06 June 2016
View article titled, Management of Diabetic Ketoacidosis in Severe Insulin Resistance
Open the PDF for Management of Diabetic Ketoacidosis in Severe Insulin Resistance in another window
Journal Articles

Effects of Leptin Replacement Therapy on Pancreatic β-Cell Function in Patients With Lipodystrophy

Ranganath Muniyappa, Rebecca J. Brown, Andrea Mari, Jalaja Joseph, Mary A. Warren, Elaine K. Cochran, Monica C. Skarulis, Phillip Gorden
Journal: Diabetes Care
Diabetes Care 2014;37(4):1101–1107
https://doi.org/10.2337/dc13-2040
Published: 08 March 2014
View article titled, Effects of Leptin Replacement Therapy on Pancreatic β-Cell Function in Patients With Lipodystrophy
Open the PDF for Effects of Leptin Replacement Therapy on Pancreatic β-Cell Function in Patients With Lipodystrophy in another window
Journal Articles

Plasma Adiponectin as a Marker of Insulin Receptor Dysfunction: Clinical utility in severe insulin resistance

Robert K. Semple, MB, PHD, Elaine K. Cochran, MSN, CRNP, Maria A. Soos, PHD, Keith A. Burling, MPHIL, David B. Savage, MD, Phillip Gorden, MD, Stephen O'Rahilly, MD
Journal: Diabetes Care
Diabetes Care 2008;31(5):977–979
https://doi.org/10.2337/dc07-2194
Published: 01 May 2008
View article titled, Plasma Adiponectin as a Marker of Insulin Receptor Dysfunction: <subtitle>Clinical utility in severe insulin resistance</subtitle>
Open the PDF for Plasma Adiponectin as a Marker of Insulin Receptor Dysfunction: <subtitle>Clinical utility in severe insulin resistance</subtitle> in another window
Includes: Supplementary data
Journal Articles

The Use of U-500 in Patients With Extreme Insulin Resistance

Elaine Cochran, MSN, CRNP, Carla Musso, MD, Phillip Gorden, MD
Journal: Diabetes Care
Diabetes Care 2005;28(5):1240–1244
https://doi.org/10.2337/diacare.28.5.1240
Published: 01 May 2005
View article titled, The Use of U-500 in Patients With Extreme Insulin Resistance
Open the PDF for The Use of U-500 in Patients With Extreme Insulin Resistance in another window
Journal Articles

Lessening the Burden of Diabetes: Intervention Strategies

Richard C Eastman, MD, Robert Silverman, MD, PHD, Maureen Harris, PHD, Jonathan C Javitt, MD, MPH, Yen Pin Chiang, PHD, Phillip Gorden, MD
Journal: Diabetes Care
Diabetes Care 1993;16(8):1095–1102
https://doi.org/10.2337/diacare.16.8.1095
Published: 01 August 1993
View article titled, Lessening the Burden of Diabetes: Intervention Strategies
Open the PDF for Lessening the Burden of Diabetes: Intervention Strategies in another window